Selected Publications
Selukar S, Prince DK, May S. A framework for sequential monitoring of individual N-of-1 trials and combining results across a series of sequentially monitored N-of-1 trials. Clin Trials 2025 Jan 2:17407745241304284. doi: 10.1177/17407745241304284. Epub ahead of print. PMID: 39744919.
Sharma A, Selukar S, Bi Y, Merlocco A, Morin CE, Goode C, Rai P, Towbin JA, Hankins JS, Gottschalk S, Triplett B, Johnson JN. Impact of hematopoietic cell transplantation on myocardial fibrosis in young patients with sickle cell disease. Blood 2024 Aug 8;144(6):672-675. doi: 10.1182/blood.2023023028. PMID: 38691679; PMCID: PMC11347799.
Selukar S. Investigating the Benefits of Collecting Low- and Moderate-Grade Adverse Events in Cancer Clinical Trials. J Clin Oncol 2024 Jul 1;42(19):2358-2359. doi: 10.1200/JCO.24.00197. Epub 2024 Apr 24. PMID: 38657182.
Naik S, Li Y, Talleur AC, Selukar S, Ashcraft E, Cheng C, Madden RM, Mamcarz E, Qudeimat A, Sharma A, Srinivasan A, Suliman AY, Epperly R, Obeng EA, Velasquez MP, Langfitt D, Schell S, Métais JY, Arnold PY, Hijano DR, Maron G, Merchant TE, Akel S, Leung W, Gottschalk S, Triplett BM. Memory T-cell enriched haploidentical transplantation with NK cell addback results in promising long-term outcomes: a phase II trial. J Hematol Oncol 2024 Jun 27;17(1):50. doi: 10.1186/s13045-024-01567-0. PMID: 38937803; PMCID: PMC11212178.
Morin CE, Sharma A, Selukar S, Beasley G, Merlocco A, Goode C, Rai P, Towbin JA, Hankins JS, Johnson JN. Diffuse myocardial fibrosis occurs in young patients with sickle cell anemia despite early disease-modifying therapy. Blood 2023 Mar 16;141(11):1358-1362. doi: 10.1182/blood.2022018209. PMID: 36441963.
Selukar S, Othus M. RECeUS: Ratio estimation of censored uncured subjects, a different approach for assessing cure model appropriateness in studies with long-term survivors. Stat Med 2023 Feb 10;42(3):209-227. doi: 10.1002/sim.9610. Epub 2022 Nov 25. PMID: 36433635; PMCID: PMC9851962.
Gernsheimer TB, Brown SP, Triulzi DJ, Key NS, El Kassar N, Herren H, Poston JN, Boyiadzis M, Reeves BN, Selukar S, Pagano MB, Emerson S, May S. Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trial. Blood 2022 Sep 15;140(11):1254-1262. doi: 10.1182/blood.2022016308. PMID: 35667085.
Sanchez JI, Shankaran V, Unger JM, Madeleine MM, Selukar S, Thompson B. Inequitable access to surveillance colonoscopy among Medicare beneficiaries with surgically resected colorectal cancer. Cancer Feb 1;127(3):412-421, 2021. doi: 10.1002/cncr.33262. PMID: 33095916
Selukar S, May S, Law D, Othus M. Stratified randomization for platform trials with differing experimental arm eligibility. Clin Trials Oct;18(5):562-569, 2021. doi: 10.1177/17407745211028872. PMID: 34420417; PMCID: PMC8478711
Last update: April 2025